Logo
G

GlycoNex Inc (4168)

21 employees

GlycoNex develops and licenses anti-cancer monoclonal antibodies.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Antibody Production
Biotechnology
Pharmaceutical
New Drug Development
Biosimilar
Preclinical Research
SEC-HPLC
Medical
GlycoBind
Anti-glycan Antibody
Glycobiology

Date founded

2001

FAQ